Axsome Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
AXSM on Nasdaq
Location
One World Trade Center, 29 Th Floor, New York, NY

Insiders trading volume in the past year

Axsome Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Herriot Tabuteau Chief Executive Officer, Director, 10%+ Owner $901M -$34.6M -3.7% Nov 3, 2025
Mark Coleman Director $53.4M -$905K -1.67% Sep 8, 2025
Nick Pizzie Chief Financial Officer $8.06M -$1.95M -19.5% Feb 21, 2025
Roger Jeffs Director $7.12M -$13.4M -65.3% Sep 2, 2025
Mark Jacobson Chief Operating Officer $2.82M -$13.4M -82.6% Sep 22, 2025
R. Murdock General Counsel $2.11M -$3.65M -63.3% Jun 20, 2025
Ari Maizel Chief Commercial Officer $2.03M Feb 21, 2025
Mark E. Saad Director $1.29M -$1.14M -46.9% Sep 5, 2025
Susan Mahony Director $4.59K Jun 6, 2025

Recent Insider Transactions by Companies or Individuals for Axsome Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.